Aakha Biologics
PrivateLast Round
Debt
Jul 23, 2024
Total Funding Raised
$3.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aakha Biologics is a biotechnology company that develops next-generation multi-specific antibody immunotherapies for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aakha Biologics Comparables
Compare Aakha Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ypsilon Therapeutics | 83% | |
| Cantai Therapeutics | 82% | |
| Cullinan Oncology | 76% |
Aakha Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 23, 2024 | ||||
| Seed | Jul 17, 2024 | ||||
| Grant | May 22, 2024 | ||||
| Accelerator | May 1, 2021 |
Key People
Founding team and executive leadership
Aakha Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Opus8 | Seed |
| 82VS | Accelerator |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Grew 60% QoQ from 5 to 8 employees.
- May 24, 2026
Grew 60% QoQ from 5 to 8 employees.
Aakha Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aakha Biologics's valuation, stock price, and market status.
Is Aakha Biologics a public or private company?
Aakha Biologics is a private company.
What is the current stock price of Aakha Biologics?
Aakha Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Aakha Biologics worth (valuation)?
Valuation information for Aakha Biologics is not publicly available.
Can I buy Aakha Biologics stock?
Aakha Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aakha Biologics's last funding round?
Aakha Biologics's most recent funding round was Debt on July 23, 2024.
Who are the main investors in Aakha Biologics?
Key investors in Aakha Biologics include National Cancer Institute, Opus8, 82VS, Cancer Prevention and Research Institute of Texas.
Will Aakha Biologics IPO soon?
No public IPO plans have been announced for Aakha Biologics.
How can I track Aakha Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aakha Biologics's secondary market activity and sign up for updates.